ATA598975A - Verfahren zur herstellung eines praparates zur behandlung interferonsensibler infektionskrankheiten - Google Patents

Verfahren zur herstellung eines praparates zur behandlung interferonsensibler infektionskrankheiten

Info

Publication number
ATA598975A
ATA598975A AT598975A AT598975A ATA598975A AT A598975 A ATA598975 A AT A598975A AT 598975 A AT598975 A AT 598975A AT 598975 A AT598975 A AT 598975A AT A598975 A ATA598975 A AT A598975A
Authority
AT
Austria
Prior art keywords
interferon
preparation
manufacturing
treatment
infectious diseases
Prior art date
Application number
AT598975A
Other languages
English (en)
Other versions
AT343797B (de
Original Assignee
Stickl Helmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19742437166 external-priority patent/DE2437166C3/de
Application filed by Stickl Helmut filed Critical Stickl Helmut
Publication of ATA598975A publication Critical patent/ATA598975A/de
Application granted granted Critical
Publication of AT343797B publication Critical patent/AT343797B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • A61K39/285—Vaccinia virus or variola virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24132—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/811—Interferon

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
AT598975A 1974-08-01 1975-08-01 Verfahren zur herstellung eines praparates zur behandlung interferonsensibler infektionskrankheiten AT343797B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19742437166 DE2437166C3 (de) 1974-08-01 Arzneimittel gegen interferonsensible, viralbedingte Infektionskrankheiten

Publications (2)

Publication Number Publication Date
ATA598975A true ATA598975A (de) 1977-10-15
AT343797B AT343797B (de) 1978-06-12

Family

ID=5922207

Family Applications (1)

Application Number Title Priority Date Filing Date
AT598975A AT343797B (de) 1974-08-01 1975-08-01 Verfahren zur herstellung eines praparates zur behandlung interferonsensibler infektionskrankheiten

Country Status (13)

Country Link
US (1) US4053582A (de)
JP (1) JPS5141420A (de)
AT (1) AT343797B (de)
BE (1) BE831691A (de)
CA (1) CA1057195A (de)
CH (1) CH614627A5 (de)
DK (1) DK141835C (de)
ES (1) ES439966A1 (de)
FR (1) FR2280390A1 (de)
GB (1) GB1517540A (de)
NL (1) NL7509136A (de)
SE (1) SE7508565L (de)
ZA (1) ZA754725B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2714665A1 (de) * 1977-04-01 1978-10-05 Mayr Anton Praeparat zur behandlung von herpes zoster und anderen herpes-infektionen, sowie verfahren zu seiner herstellung
US5514376A (en) * 1979-09-04 1996-05-07 Merck & Co., Inc. Cell culture of hepatitis A virus
US4309416A (en) * 1979-09-20 1982-01-05 Research Corporation Vaccines from taxonomically similar organisms
EP0037441B1 (de) * 1980-03-10 1984-05-09 Seiji Arakawa Pharmazeutische Zusammensetzungen zur zellulären Immunopotentialisation und als Antitumor-Mittel, Verfahren zu ihrer Herstellung und der darin verwendete Mikroorganismus
US4315914A (en) * 1980-04-04 1982-02-16 Seiji Arakawa Pharmaceutical compositions useful as cellular immunopotentiator and antitumor agent and process for production thereof
EP0077063B1 (de) * 1981-10-13 1988-03-16 Exovir, Inc. Interferon enthaltende Zusammensetzungen und die Anwendung dieser Zusammensetzungen in der Behandlung von Herpesinfektionen, prämalignen Hautverletzungen, Hautmalignitäten und Psoriasis
EP0080032A3 (de) * 1981-11-20 1985-11-13 Enzo Biochem, Inc. Pharmazeutische Zubereitung für die Behandlung von herpetischen Verletzungen
US4497795A (en) * 1982-12-13 1985-02-05 The Texas A&M University System Method of regulating appetite and efficiency of food utilization employing interferon
US4820515A (en) * 1982-12-13 1989-04-11 Texas A&M University System Method of using interferon in low dosage to regulate appetite and efficiency of food utilization
US5910304A (en) * 1982-12-13 1999-06-08 Texas A&M University System Low-dose oral administration of interferons
HU197517B (en) * 1984-07-30 1989-04-28 Laszlo Csatary Process for production of terapeutical composition applicable against virus infection
US4820514A (en) * 1985-12-30 1989-04-11 Texas A&M University System Low dosage of interferon to enhance vaccine efficiency
CA1320905C (en) * 1986-11-06 1993-08-03 Joseph M. Cummins Treatment of immuno-resistant disease
ZA878295B (en) * 1986-11-06 1988-05-03 Amarillo Cell Culture Co. Inc. Treatment of immuno-resistant disease
US4758426A (en) * 1987-06-11 1988-07-19 Ramsdell Bruce V Therapeutic toilet solution and method of dispersion
US5017371A (en) * 1988-01-06 1991-05-21 Amarillo Cell Culture Company, Incorporated Method for reducing side effects of cancer therapy
US4867975A (en) * 1988-01-27 1989-09-19 University Of Delaware Live attenuated temperature-sensitive avian infectious bronchitis virus vaccines and preparation and use thereof
US5215745A (en) * 1988-04-27 1993-06-01 United Cancer Research Institute Method for treating viral diseases with attenuated virus
US5124148A (en) * 1988-04-27 1992-06-23 United Cancer Research Institute Method for treating viral diseases with attenuated virus
PT1314431E (pt) * 1993-04-30 2008-10-24 Wellstat Biologics Corp Composições purificadas de vírus da doença de newcastle
FR2707458B1 (fr) * 1993-07-12 1995-10-06 Sagal Ingrédients alimentaires obtenus par fermentation avec S. Boulardii et aliments les contenant.
US6140107A (en) * 1996-09-25 2000-10-31 Viva America Marketing, Inc. Organometallic-metabolizing yeast
US20030138454A1 (en) * 1997-06-09 2003-07-24 Oxxon Pharmaccines, Ltd. Vaccination method
GB9711957D0 (en) * 1997-06-09 1997-08-06 Isis Innovation Methods and reagents for vaccination
GB0118532D0 (en) * 2001-07-30 2001-09-19 Isis Innovation Materials and methods relating to improved vaccination strategies
WO2003047617A2 (en) * 2001-11-30 2003-06-12 Isis Innovation Limited Vaccine
GB2382578A (en) * 2001-11-30 2003-06-04 Isis Innovation Fowlpox-based vaccine
US20050175627A1 (en) * 2003-09-24 2005-08-11 Oxxon Therapeutics Ltd. HIV pharmaccines
DE10349115A1 (de) * 2003-10-22 2005-06-16 Biosyn Arzneimittel Gmbh Kombinationspräparat zur Behandlung der Sepsis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3429965A (en) * 1966-08-01 1969-02-25 Sterling Drug Inc Avian pox virus vaccine and process of preparing same

Also Published As

Publication number Publication date
GB1517540A (en) 1978-07-12
DK141835C (da) 1980-11-10
DK141835B (da) 1980-06-30
FR2280390B1 (de) 1980-04-11
DK347775A (da) 1976-02-02
AT343797B (de) 1978-06-12
CH614627A5 (de) 1979-12-14
US4053582A (en) 1977-10-11
SE7508565L (sv) 1976-02-02
CA1057195A (en) 1979-06-26
DE2437166A1 (de) 1976-02-19
NL7509136A (nl) 1976-02-03
ES439966A1 (es) 1977-03-01
ZA754725B (en) 1976-06-30
DE2437166B2 (de) 1977-01-27
BE831691A (fr) 1975-11-17
JPS5141420A (de) 1976-04-07
FR2280390A1 (fr) 1976-02-27

Similar Documents

Publication Publication Date Title
ATA598975A (de) Verfahren zur herstellung eines praparates zur behandlung interferonsensibler infektionskrankheiten
AT347038B (de) Verfahren zur herstellung eines diaetpraeparats
AT348845B (de) Verfahren zur herstellung eines u-foermigen koerpers
AT353415B (de) Verfahren zur herstellung eines pharma- zeutischen praeparates
AT354408B (de) Verfahren zur herstellung eines oxydations- katalysators
AT350726B (de) Verfahren zur herstellung einer blut- gerinnungsfoerdernden praeperation aus menschlichem blutplasma
CH617054B (de) Verfahren zur herstellung eines vliesstoffes.
AT349864B (de) Verfahren zur herstellung eines neuen nahrungsmittels
AT346850B (de) Verfahren zur herstellung von epoxiden
ATA639275A (de) Verfahren zur herstellung neuer rifamycine
DD131019A5 (de) Verfahren zur herstellung eines 2-desoxystreptaminaminoglycosides
ATA939874A (de) Bindepechs eines verfahren zur herstellung
ATA845575A (de) Verfahren zur herstellung neuer substituierter benzophenone
AT348318B (de) Verfahren zur herstellung eines formkoerpers
ATA885874A (de) Verfahren zur herstellung eines schwammartigen keramischen korpers
ATA564575A (de) Verfahren zur herstellung eines detergens
AT334398B (de) Verfahren zur herstellung neuer, ungesattigter, phosphorhaltiger carbonsaurederivate
AT338515B (de) Verfahren zur herstellung eines katalysators
AT338514B (de) Verfahren zur herstellung eines katalysators
DD128852A5 (de) Verfahren zur herstellung neuer d-homosteroide
AT338513B (de) Verfahren zur herstellung eines katalysators
AT349159B (de) Verfahren zur herstellung neuer bufadienolid- und bufatrienolidaether
ATA951574A (de) Verfahren zur herstellung eines horizontalfilterbrunnens
AT341077B (de) Verfahren zur herstellung einer insulinzubereitung
DD124252A5 (de) Verfahren zur herstellung neuer adenosinnitrate

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee